Recombinant immune complexes (rICs) as a therapeutic for Multiple Sclerosis (MS): effect on myeloid cell activation
Jin Wang(Nanjing Drum Tower Hospital), Elizabeth Fitzpatrick, Kwame Torgbe(University of Tennessee Health Science Center), Henrik S. Olsen(Gliknik (United States)), David S. Block(Gliknik (United States)), Samuel Worcester Rice(University of Tennessee Health Science Center), Danehy Caroline Margaret(University of Tennessee Health Science Center), Fridtjof Thomas(University of Tennessee Health Science Center), Kellie Nicole Brown(University of Tennessee Health Science Center), Scott E. Strome(Northwestern Medicine Lake Forest Hospital)
Cited by 0
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|548
618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target
|The Journal of Urology|2005|387